Company intelligence / Profile preview

Meiriki Japan

Ownership: Private
Development stage: Commercial

Overview

Meiriki Japan focuses on the development and sale of high-quality nutraceuticals and functional foods. Products such as Reuteri Probiotics, LeverRen, and Ca Easy are manufactured to pharmaceutical-grade standards. The company emphasizes sustainable sourcing for ingredients like palm oil and marine products.

Therapeutic areas: OtherEndocrinologyGastroenterology
Modalities: ProbioticsNutritional supplements (e.g., seaweed calcium, cod-derived ingredients)
Industry: Food & Nutrition

Partnerships

Sustainable ingredient suppliers certified by RSPO for palm oil production

Beyond the preview

Go deeper on Meiriki Japan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meiriki Japan.

Explore the full profile